(Q34451219)

English

Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer (English)

1 reference

Europe PubMed Central

2 August 2017

phase II clinical trial

0 references

object named as

Andrew J Vickers

5

0 references

author name string

Jonathan L Silberstein

1

1 reference

Europe PubMed Central

2 August 2017

Stephen A Poon

2

1 reference

Europe PubMed Central

2 August 2017

Daniel D Sjoberg

3

1 reference

Europe PubMed Central

2 August 2017

Alexandra C Maschino

4

1 reference

Europe PubMed Central

2 August 2017

Aaron Bernie

6

1 reference

Europe PubMed Central

2 August 2017

Badrinath R Konety

7

1 reference

Europe PubMed Central

2 August 2017

W Kevin Kelly

8

1 reference

Europe PubMed Central

2 August 2017

James A Eastham

9

1 reference

Europe PubMed Central

2 August 2017

publication date

17 April 2015

1 reference

Europe PubMed Central

2 August 2017

BJU International

1 reference

Europe PubMed Central

2 August 2017

116

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

50-56

1 reference

Europe PubMed Central

2 August 2017

Cancer statistics for Hispanics/Latinos, 2012.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

High-risk localized prostate cancer: a case for early chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

6 July 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Toward patient-centered drug development in oncology

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12676

21 January 2018

Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

27 October 2018

Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219923

27 October 2018

Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24552276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24552276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24552276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/24552276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN clinical practice guidelines in oncology: testicular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24552276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/BJU.12676

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34451219&oldid=1667439565"